Ada’s Clinical AI combines with Fullspan’s digital health ecosystem, the largest platform reaching health-minded consumers in the U.S., to help people understand their symptoms, find trusted doctors, and get to the right care faster.
Las Vegas, NV – Tuesday, October 21, 2025 – Ada Health and Fullspan Health today announced a strategic partnership that incorporates Ada’s clinical artificial intelligence into Fullspan Health’s end-to-end suite of capabilities that reach millions of people each month. The collaboration aims to reduce time to treatment by offering consumers evidence-based, personalized guidance and tailored pathways to the right care and treatment using cutting-edge, Clinical AI.
“This partnership allows pharma and life science clients to meet people at the moment they are searching for answers,” said Suzy Jackson, Chief Commercial Officer at Fullspan Health. “By combining Fullspan Health’s reach and Ada’s clinical intelligence, we can help the millions of people who are undiagnosed or misdiagnosed access the right therapy and care faster than ever before.”
Through this integration, Ada and Fullspan Health are redefining the patient journey, aiming to close persistent diagnostic gaps across often under-diagnosed areas such as autoimmune conditions and women’s health. Clinical intelligence becomes an active force in every interaction, helping people move from uncertainty to action while giving healthcare and life sciences partners a compliant, measurable way to engage patients earlier. The collaboration signals a new era of predictive, data-informed, and patient-empowered care.
“Fullspan’s unparalleled reach makes Ada’s Clinical AI accessible to millions of Americans seeking care,” said Jacob Plummer, Chief Commercial Officer at Ada Health. “Together, we’re turning awareness into action, helping people move from understanding their symptoms to finding the right doctor and beginning treatment sooner.”
Ada Health is a global leader in Clinical AI, trusted by healthcare organizations and life sciences partners to enable earlier, safer, and more equitable access to diagnosis and treatment. With more than 50 peer-reviewed publications and 40 million assessments completed worldwide, Ada provides one of the most clinically validated AI platforms in healthcare, offering a proven, compliant framework for patient engagement and activation.
Fullspan Health brings together the most comprehensive suite of capabilities and services in the industry to evolve and modernize the patient experience. Fullspan Health leverages the reach of RVO Health, the largest consumer health platform in the U.S., combining clinical expertise, trusted content, and data-driven technologies to help life sciences companies engage patients with relevance, scale, and impact. To learn more visit fullspanhealth.com and about.ada.com
ABOUT ADA HEALTH
Ada Health combines clinical expertise and advanced AI to help people and health organizations act on insights earlier. Built by doctors, scientists, and engineers, Ada’s medical-grade platform transforms real-world data into actionable guidance—empowering individuals to understand their symptoms and helping partners across healthcare and life sciences deliver more timely, personalized care.
With over 40 million assessments completed worldwide, Ada’s clinically validated technology is trusted by leading health systems, insurers, and pharmaceutical companies to improve outcomes, streamline care pathways, and build a smarter, more connected future of health. Learn more at about.ada.com.
ABOUT FULLSPAN HEALTH
Fullspan Health, an offering from RVO Health, is helping life sciences companies engage patients across the entire healthcare journey. Offering end-to-end capabilities, from patient finding and engagement to pharmacy and care services and medication adherence, Fullspan Health combines trusted content, innovative digital tools, and data-driven insights to deliver a seamless, patient-centric experience. We are driving technology-enabled solutions that modernize the patient and provider experience and enable brands and enterprises to operate as true B2C healthcare companies.